1. Anthony HM (1993) Some methodological problems in the assessment of complementary therapy. In: Lewith GT, Aldridge D (eds) Clinical research methodology for complementary therapies. Hodder & Stoughton, London, pp 108–121
2. Antman K, Benson MC, Chabot J et al (2001) Complementary and alternative medicine: the role of the cancer center. J Clin Oncol 19(Suppl):55–60
3. Bensoussan A (1993) Contemporary acupuncture research. Am J Acupunct 19:357–366
4. Bensoussan A, Myers SP (1996) Towards a safer choice: the practice of traditional Chinese medicine in Australia. University of Western Sydney Macarthur, Sydney
5. Blackhall FH, O’brien M, Schmid P et al (2010) A Phase I Study of Vandetanib in combination with Vinorelbine/Cisplatin or Gemcitabine/Cisplatin as first-line treatment for advanced non-small cell lung cancer. J Thorac Oncol 5(8):1285–1288